[1]
“Changing the «rules of the game» in the treatment of patients with heart failure: a focus on empagliflozin”, UJC, vol. 29, no. 5-6, pp. 71–90, Jan. 2023, doi: 10.31928/2664-4479-2022.5-6.7190.